$4.00
-0.05 (-1.26%)
Santarus, Inc. (SNTS)
CAPS Rating:
A pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.

RSS Headlines
Fool UK